AGIOS PHARMACEUTICALS, INC.AGIO
Market cap
$1.5B
P/E ratio
| Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Product | - | - | - | - | - | 14 | 60 | 121 | - | 12 | 27 | 36 |
| Royalty | - | - | - | - | - | 7 | 11 | 10 | - | 3 | - | - |
| Total revenue | - | - | - | - | - | 94 | 118 | 203 | - | 14 | 27 | 36 |
| Cost of sales | - | - | - | - | - | 1 | 1 | 3 | - | 2 | 3 | 4 |
| Research and development | 55 | 100 | 142 | 220 | 293 | 341 | 411 | 367 | 257 | 280 | 296 | 301 |
| Selling, general and administrative | - | - | - | - | - | 114 | 132 | 149 | 121 | 122 | 120 | 157 |
| Total operating expenses | - | - | - | - | - | - | 544 | 519 | 378 | 403 | 418 | 462 |
| Loss from operations | -39 | -54 | -119 | -201 | -321 | -362 | -426 | -316 | -378 | -389 | -391 | -426 |
| Gain on sale of contingent payments | - | - | - | - | - | - | - | - | - | 128 | - | 889 |
| Gain (Loss) on Disposition of Business | - | - | - | - | - | - | - | - | 7 | - | - | 200 |
| Royalty Income, Nonoperating | - | - | - | - | - | - | - | - | - | 10 | - | - |
| Interest income, net | - | - | - | - | - | - | - | - | - | - | 33 | 48 |
| Other income, net | - | - | - | - | - | - | - | - | 14 | 7 | 6 | 6 |
| Net income (loss) before taxes | -39 | -54 | -118 | -198 | - | - | - | - | -357 | -232 | -352 | 718 |
| Income tax expense | 1 | -0 | - | - | - | - | - | - | - | - | - | 44 |
| Net income (loss) | -39 | -54 | -118 | -198 | -315 | -346 | -411 | -327 | 1,605 | -232 | -352 | 674 |
| Earnings Per Share, Basic | - | - | - | - | - | - | - | - | 26.55 | -4.23 | -6.33 | 11.86 |
| Earnings Per Share, Diluted | - | - | - | - | - | - | - | - | 26.55 | -4.23 | -6.33 | 11.64 |